2025年2月11日 · Oabf 25mg Tablet is used to treat symptoms of overactive bladder that includes increased or frequent urination, urgent need to urinate and inability to control urination. It helps to relax the muscle surrounding the bladder and increase it's ability to store urine.

米拉贝隆缓释片（倍加安）是由江苏华鑫制药有限公司生产的一种新型的高选择性β3受体激动剂，用于治疗膀胱过度活动症（OAB），它通过选择性作用于膀胱平滑肌来缓解尿频、尿急和尿失禁等症状。

Mirabegron 25mg and 50mg, solifenacin 5mg, and tolterodine 4mg were all associated with greater improvement from baseline than placebo, with the numerical change from baseline to end of treatment in incontinence episodes higher in the oldest group.

MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage. Important Safety Information. Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

Overactive bladder (OAB) is a chronic condition of the lower urinary tract characterized by symptoms of urinary urgency, with or without urgency incontinence, usually with urinary frequency and nocturia. Mirabegron is selective beta 3-adrenoceptor agonist available as a 25 mg and 50 mg extended-release (ER) tablet.

A： 膀胱過動症 (Overactive bladder；OAB) 是一種常見的疾病，主要症狀為 頻尿、急尿、夜尿和急迫性尿失禁。一般人的膀胱儲尿量約為四百西西， 但膀胱過動患者只要兩百西西左右就有尿意。根據國際尿失禁醫學會定

Mirabegron is selective beta 3-adrenoceptor agonist available as a 25 mg and 50 mg extended-release (ER) tablet. It is approved for the treatment of OAB with symptoms of urgency, urgency incontinence, and urinary frequency. The manufacturer has requested that mirabegron be listed in a manner similar to other second-line OAB drugs.

2024年8月8日 · MIRAGRON ER 25, containing Mirabegron (25mg), offers an effective treatment for managing overactive bladder (OAB) symptoms and improving urinary control. By relaxing the bladder muscle and increasing its capacity, this medication helps reduce the frequency and urgency of urination, as well as episodes of incontinence.

Oab-F 25mg Er Tablet belongs to the group of medications called ‘urinary antagonists' or 'antispasmodics' primarily used to treat overactive bladder (OAB) symptoms. Overactive bladder is a condition in which the urinary bladder muscles constrict uncontrollably, thereby causing an urgent need to urinate, frequent urination, and an inability to ...

2024年8月8日 · MIRAGRON S 25/5, containing Mirabegron Extended Release (25mg) and Solifenacin Succinate (5mg), offers an effective combination therapy for managing overactive bladder (OAB) symptoms and improving urinary control.